6505-01-505-4632 Citalopram hydrobromide tablets
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 18, 2026
- Last price paid
- …
- Standard price
- $7.86 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 3
- Awards on record
- 16
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Citalopram hydrobromide tablets
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 07-MAR-03
- Unit
- BT
- NSN
- 6505-01-505-4632
- NIIN
- 01-505-4632
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | 1HT23 | A (Active) | 5 (Secondary reference) / 9 (Was the design control reference) | NDC60429-0174-01 | DLA approved-source file |
| MYLAN PHARMACEUTICALS INC | 3KJG9 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00378-6232-01 | DLA approved-source file |
| ALLERGAN USA INC | 4END5 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00456-4020-01 | DLA approved-source file |
| ALLERGAN USA INC | 4END5 | A (Active) | 3 (Design control reference) / 1 (Not identify an item of production without the use of additional information) | CELEXA | FLIS part list |
| 6JS41 | A (Active) | 3 (Design control reference) / 1 (Not identify an item of production without the use of additional information) | NDC60429-0174-01 | FLIS part list | |
| 89875 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 03-0049 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Product characteristics
| Code | Requirement | Description |
|---|---|---|
| AJUC | American hospital formulary service classification number | 281604 |
| CXCY | Part name assigned by controlling agency | CITALOPRAM HYDROBROMIDE (CELEXA) TABLETS 20MG BT 100S |
| FEAT | Special features | ANTIDEPRESSANT; ORAL ADMINISTRATION; 20MG 100 PER BOTTLE |
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- PINC
- 0067389
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BT | $6.16 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $6.16 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $6.16 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $7.86 | 1 (1) | U (Unclassified) | Q (36 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
Packaging
FLIS packaging data of this item
FLIS packaging
- Unit pack weight
- 1 lb
- Unit pack cube
- 0.492 cu ft
- Level A
- Z (Special requirement)
- Level B
- Z (Special requirement)
- Unit container
- ZZ (Special requirement)
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0351DIBBS only | 6505-01-505-4632 | Citalopram hydrobromide tablets | 5 | BT | $7.86 per BT | … | … | No set-aside | No | November 12, 2026 | November 18, 20264 days left |
| SPE2DP27T0218DIBBS only | 6505-01-505-4632 | Citalopram hydrobromide tablets | 1 | BT | $7.86 per BT | … | … | No set-aside | No | November 2, 2026 | November 9, 2026Closed |
| SPE2DP26T5367DIBBS only | 6505-01-505-4632 | Citalopram hydrobromide tablets | 4 | BT | $7.86 per BT | … | … | No set-aside | November 11, 2026First seen | October 5, 2026Closed |
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
16 award lines since 2013, 3 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 0AG09SZY HOLDINGS, LLC | 7 | October 23, 2026 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 7 | November 19, 2025 |
| 3W8H0MR UNLIMITED, LLC | 2 | September 23, 2021 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 4 | 2 |
| 2024 | 1 | 1 |
| 2021 | 2 | 2 |
| 2020 | 4 | 2 |
| 2017 | 2 | 1 |
| 2016 | 1 | 1 |
| 2013 | 1 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
13 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | SZY HOLDINGS, LLC | $435 | 6 |
| 2 | MR UNLIMITED, LLC | $79 | 2 |
| 3 | DMS PHARMACEUTICAL GROUP INC | $38 | 5 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26F0802From the item's award history | November 19, 2025 | DMS PHARMACEUTICAL GROUP INC | $3 |
| SPE2DP26F0541From the item's award history | October 30, 2025 | DMS PHARMACEUTICAL GROUP INC | $7 |
| SPE2DP26F0438From the item's award history | October 29, 2025 | DMS PHARMACEUTICAL GROUP INC | $14 |
| SPE2DP25P0508From the item's award history | June 24, 2025 | SZY HOLDINGS, LLC | $47 |
| SPE2DP25P0046From the item's award history | October 15, 2024 | SZY HOLDINGS, LLC | $102 |
| SPE2DP21P1059From the item's award history | September 23, 2021 | MR UNLIMITED, LLC | $57 |
| SPE2DP21P0596From the item's award history | April 14, 2021 | SZY HOLDINGS, LLC | $206 |
| SPE2DP21P0231From the item's award history | November 9, 2020 | SZY HOLDINGS, LLC | $9 |
| SPE2DP20P1244From the item's award history | September 28, 2020 | MR UNLIMITED, LLC | $23 |
| SPE2DP20P1151From the item's award history | September 13, 2020 | SZY HOLDINGS, LLC | $18 |
| SPE2DP20P1109From the item's award history | September 2, 2020 | SZY HOLDINGS, LLC | $53 |
| SPE2DX15D9383/4740From the item's award history | February 21, 2017 | DMS PHARMACEUTICAL GROUP INC | $10 |
| SPE2DX15D9383/4743From the item's award history | February 21, 2017 | DMS PHARMACEUTICAL GROUP INC | $3 |
Showing 1 to 10 of 13 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.